An Interview with I. Glenn Cohen on Controversial Health Issues
In an interview with PBS.org, Faculty Director I. Glenn Cohen, sat down with Tavis Smiley to discuss important health issues, such as experimental Ebola drugs and prescription opiate use in the U.S.
From the interview:
[...] Smiley: Let me start with your assessment of - it’s been a little while now - your assessment of how this Ebola crisis has been handled to date.
Cohen: So I think the general sense of people who work in public health is that it’s not been a very strong handling of it. There were about 20 Ebola outbreaks since 1976. This was predictable that this was coming. You had the first index case in December 2013 of this outbreak, but it took until August for the WHO to declare a public health emergency and only more recently has it issued its roadmap. And in general, I think most people feel as though this could have been contained much more quickly. And one of the ways to have done that would have been to do more capacity-building of the infrastructure for healthcare in many of these countries. [...]bioethics biotechnology health law policy human subjects research i. glenn cohen international pharmaceuticals public health